Paper Details
- Home
- Paper Details
Apraclonidine and clonidine: a comparison of efficacy and side effects in normal and ocular hypertensive volunteers.
Author: CaglarY, ElibolO, GülerC, YükselN
Original Abstract of the Article :
We performed a prospective, randomized double blind study comparing the cardiovascular and intraocular pressure (IOP) effects of unilateral therapy with clonidine 0.125% and apraclonidine hydrochloride 1.0% in 15 normal and 15 ocular hypertensive volunteers. Baseline values were obtained prior to in...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1007/BF00917987
データ提供:米国国立医学図書館(NLM)
Apraclonidine vs. Clonidine: Navigating the Eye Pressure Desert
This research takes us on a fascinating journey through the world of ocular hypertension, a condition akin to a desert where pressure builds up within the eye. The study compares the effectiveness and side effects of two medications, apraclonidine and clonidine, both aiming to reduce this pressure, much like finding a well to alleviate thirst. The study employed a prospective, randomized double-blind study, a meticulous approach akin to a seasoned desert explorer meticulously charting his course.
Apraclonidine Emerges as a More Effective Oasis
The study reveals that apraclonidine was more effective than clonidine in lowering intraocular pressure (IOP), achieving a maximum decrease of 31.4% in normal volunteers and 33.9% in ocular hypertensive patients. This is like discovering a plentiful oasis that provides much-needed relief from the scorching desert sun. Moreover, apraclonidine was found to be safer, with no significant changes in blood pressure or pulse rate. This is akin to finding an oasis that doesn't harbor dangerous predators.
Navigating the Side Effects of Ocular Hypertension Treatment
The study emphasizes the importance of considering potential side effects, like navigating a desert where even the most welcome oasis may be accompanied by certain risks. The study found that apraclonidine did cause eyelid retraction, conjunctival blanching, and mydriasis, which is like encountering a prickly cactus or a swift desert wind. However, these side effects were not statistically significant. The researchers note that while clonidine produced a significant decrease in contralateral IOP, this reduction was not statistically significantly different than that of placebo, suggesting that it may not be as effective as apraclonidine.
Dr. Camel's Conclusion
This research offers valuable insights into the world of ocular hypertension, providing a detailed comparison of two medications. It underscores the importance of finding the right treatment approach, much like navigating a complex desert landscape. While apraclonidine emerges as a more effective and safer option, the researchers highlight the need to carefully consider potential side effects, just as a wise traveler assesses the risks and benefits of each oasis.
Date :
- Date Completed 1992-12-23
- Date Revised 2019-10-21
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.